1. Home
  2. HRB vs PRAX Comparison

HRB vs PRAX Comparison

Compare HRB & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo H&R Block Inc.

HRB

H&R Block Inc.

HOLD

Current Price

$30.99

Market Cap

4.1B

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$299.14

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRB
PRAX
Founded
1955
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
9.6B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
HRB
PRAX
Price
$30.99
$299.14
Analyst Decision
Sell
Strong Buy
Analyst Count
2
15
Target Price
$41.00
$572.13
AVG Volume (30 Days)
2.2M
309.6K
Earning Date
05-06-2026
05-01-2026
Dividend Yield
5.51%
N/A
EPS Growth
6.55
N/A
EPS
4.39
N/A
Revenue
$3,159,931,000.00
N/A
Revenue This Year
$4.39
N/A
Revenue Next Year
$3.21
$6,395.88
P/E Ratio
$6.96
N/A
Revenue Growth
N/A
N/A
52 Week Low
$28.16
$26.70
52 Week High
$64.62
$354.87

Technical Indicators

Market Signals
Indicator
HRB
PRAX
Relative Strength Index (RSI) 44.98 43.28
Support Level $28.27 $290.36
Resistance Level $32.65 $322.32
Average True Range (ATR) 1.05 16.93
MACD 0.33 -3.50
Stochastic Oscillator 47.28 22.92

Price Performance

Historical Comparison
HRB
PRAX

About HRB H&R Block Inc.

H&R Block Inc provides income tax return preparation services, digital do-it-yourself tax solutions, and other services related to income tax preparation to the general public in the United States, Canada, and Australia. The company mainly prepares tax returns for customers within the United States through its company-owned offices, franchise locations, and online tax software. The vast majority of H&R Block's offices are located in the U.S. The company derives the majority of its total revenue from the U.S. assisted tax preparation fees. Revenue from franchise and product royalties and digital do-it-yourself tax solutions is also relatively.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: